No Detail Found!

Preliminary Survey Report of Eye Cancers in Pakistan

Author(s)
Tayyab Afghani Department of Ophthalmology, Al-Shifa Trust Eye Hospital, Rawalpindi, Pakistan
Haroon Awan Department of Public Health/Ophthalmology, Avicenna Consultants, Islamabad, Pakistan
Asad Aslam Khan Department of Ophthalmology, King Edward University and Mayo Hospital, Lahore, Pakistan
Abstract
To estimate the magnitude of eye cancer and its annual frequency, extrapolated from major eye care centres of the country. Study Design: Observational study. Place and Duration of the Study: Data were obtained from ten dedicated eye care institutions of three provinces of Pakistan, from January to December 2022. Methodology: This is the report of the rst eye cancer survey in Pakistan under the auspices of the National Committee of Eye Health. Eye care institutions, along with major stakeholders involved in the prevention and control of eye cancer, were requested to provide the annual data on tumours of the eye as well as information related to the situation analysis of eye cancer services. Results: The number of eye tumours reported in one year was 1705; 51% were malignant and 49% were benign. Eight hundred and seventy-seven cases of eye cancers were diagnosed in a year; 38% were eyelid cancers, 31% were intraocular tumours, and 16% were ocular surface tumours, while 15% were cancers of the orbit. KPK had the highest percentage of eyelid cancers (72%), and Sindh had the highest percentage of intraocular cancers (40%). Conclusion: It is estimated that there are 4 cases of eye cancer per million population of Pakistan and an almost similar number of benign eye tumours. Thus, it is estimated that 8 cases of eye tumours per million population are examined annually. Cost and lack of facilities were found to be major limitations towards eye cancer control.
Publication Details
Page(s) 784-788
Published Journal: Journal of the College of Physicians and Surgeons Pakistan, Volume: 35, Issue: 6, Year: 2025

Request the full text from PASTIC

Keywords
Pakistan, Ophthalmology, Eye malignancies, Eye surveys, Tumours of eye
References
Honavar SG,Manjandavida FP .2015 .Tumors of the ocular surface: A review. Indian J Ophthalmol, 10(3) : 156912-4738.
Fabian ID,Abdallah E,Abdullahi SU,Abdulqader RA,Boubacar SA,Ademola-Popoola DS .2020 .Global retinoblastoma presentation and analysis by national income level. JAMA Oncol, 0336(5) : 685-95.
Osazuwa Peters N,Christopher KM,Hussaini AS,Behera A,Walker RJ,Varvares MA .2016 .Predictors of stage at presentation and outcomes of head and neck cancers in a university hospital setting. Head neck, 10(S1) : E1826-32.
Harvey Thompson,Yetukuri A,Hansen M,Simpson AR,Boakye MC,Varvares EA,MA EA .2020 .Rising incidence of late stage head and neck cancer in the United States. Cancer, 10(5) : 1090-1.
Damato B .2001 .Time to treatment of uveal melanoma in the United Kingdom. Eye, 51(2) : 155-8.
Leung AK,DeAngelis DD,Hurwitz JJ,Simpson ER,Oestreicher JH,Ing E .2007 .Surgical waiting times for ocular and periocular cancer patients in Toronto. Can J Ophthalmol, 10(6) : 162-31.
Ferlay J,Ervik M,Lam F,Colombet M,Mery L,Pineros M .2018 .Global cancer observatory. Cancer Today, 10(7) : 323-6.
Pakistan WHO .2020 .Country Cancer Pro le. (Accessed on 02/12/, : .
- ,census- ,- .2024 .-population-and-housing-. , : .
Huang J,Chan SC,Ko S,Lok V,Zhang L,Lin X .2024 .Disease burden, risk factors, and temporal trends of eye cancer: A global analysis of cancer registries. Clin Exp Ophthalmol, 10(4) : 440-51.
Jain M,Rojanaporn D,Chawla B,Sundar G,Gopal L,Khetan V. .2019 .Retinoblastoma in Asia. Eye, 10(1) : 87-96.
Lam CG,Howard SC,Bou et E,Pritchard-Jones K .2019 .Science and health for all children with cancer. Science, 10(6432) : 1182-6.
Rosenblatt E,Fidarova E,Zubizarreta EH,Barton MB,Jones GW,Mackillop WJ .2018 .Radiotherapy utilization in developing countries: An IAEA study. Radiother Oncol, 05(3) : 400-5.
Baskar R,Itahana K. .2017 .Radiation therapy and cancer control in developing countries: Can we save more lives?. Int J Med Sci, 10(1) : 13.
Grover S,Gudi S,Gandhi AK,Puri PM,Olson AC,Rodin D .2016 .Radiation oncology in India: Challenges and opportunities. Semin Radiat Oncol, 11(2) : 158-63.
Wani MA,Tabish SA,Jan FA,Khan NA,Wafai ZA,Pandita KK .2013 .Cost analysis of in-patient cancer chemotherapy at a tertiary care hospital. J Cancer Res Ther, 10(3) : 119314-1482.
Sohi GK,Levy J,Delibasic V,Davis LE,Mahar AL,Amirazodi E .2021 .The cost of chemotherapy administration: A systematic review and meta-analysis. Eur J Health Econ, 10(4) : 605-20.
Zhou Y,Cai S,Jin M,Jiang C,Xu N,Duan C .2020 .Economic burden for retinoblastoma patients in China. J Med Econ, 1831518(12) : 1553-7.
Ward RL,Laaksonen MA,van Gool K,Pearson SA,Daniels B,Bastick P .2015 .Cost of cancer care for patients undergoing chemotherapy: The elements of cancer care study. Asia Pac J Clin Oncol, 10(2) : 178-86.
Silbermann M,Arnaout M,Daher M,Nestoros S,Pitsillides B,Charalambous H .2012 .Palliative cancer care in Middle Eastern countries: Accomplishments and challenges. Ann Oncol, 10(Suppl 3) : 15-28.
0

Citations

0

Downloads

35

Views